SOTK stock forecast, quote, news & analysis
Sono-Tek Corp designs and manufactures ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial, and emerging research & development/other markets... Show more
Why Sono-Tek Corporation (SOTK) Stock Is Down -39% in the Last 30 Days
Key Takeaways
- Sono-Tek Corporation (SOTK) shares fell roughly 39% over the trailing 30 days, sliding from a closing price of $7.16 on October 12, 2026 to about $4.36.
- The pullback unwound a sharp late-September rally triggered by a record $7.19 million clean-energy order, the largest aggregate order in company history.
- A fiscal second-quarter earnings miss on October 14 accelerated the decline, as earnings per share of $0.02 fell well short of the $0.05 consensus estimate.
- Management reiterated flat-to-modest fiscal 2027 revenue guidance, tempering near-term growth expectations despite a strengthening backlog.
- Fundamentals remain intact: a $9.51 million backlog, $17.7 million in cash with no debt, and 289% first-half medical market sales growth.
- As a micro-cap stock with relatively low trading liquidity, SOTK is prone to outsized price swings in both directions.
- For additional context, investors can explore this ticker's Price Targets, Earnings, and Forecast pages.
- Readers interested in AI-driven trading strategies can explore Trending AI Robots.
Sono-Tek Corporation (SOTK) Company Overview and Market Position
Sono-Tek Corporation (Nasdaq: SOTK), headquartered in Milton, New York, is a developer and manufacturer of ultrasonic spray coating systems used to apply precise, uniform thin-film coatings. Founded in 1975 and uplisted to Nasdaq, the company serves the medical, microelectronics/electronics, alternative and clean energy, industrial, and research and development markets. Its proprietary ultrasonic nozzle technology sits at the core of every machine, offering reduced overspray, material savings, and high repeatability compared with conventional coating methods.
The company's product portfolio spans in-line coating systems, multi-axis systems, and fluxing systems, with a strategic shift toward higher average selling price (ASP) production equipment. Investors follow SOTK for its exposure to medical device adoption, clean energy applications such as solar cells, fuel cells, and green hydrogen, and its ongoing transition from research-scale tools to high-volume manufacturing systems. The company operates with a debt-free balance sheet and gross margins consistently in the upper-40% to low-50% range.
Sono-Tek Corporation (SOTK) Stock Price Performance: Last 30 Days vs. Quarter
Over the last 30 days, SOTK declined approximately 39%, falling from a closing price of $7.16 on October 12, 2026 to roughly $4.36 at the latest reading. The move reflects a sharp reversal: shares rallied into mid-October before giving back those gains as earnings and guidance disappointed.
Over the last quarter, the trend is more mixed but still negative. The stock traded near $5.16 in mid-August, dipped to about $4.43 in mid-September, then surged to a peak around $7.16 by mid-October before retreating again. Measured over the full three-month period, SOTK is down roughly 15%, underscoring elevated volatility and a net downward drift despite a meaningful interim rally.
What Drove SOTK Stock Price in the Last 30 Days
The 30-day decline was shaped by two opposing catalysts. On September 30, 2026, the company announced a record $7.19 million in orders from an existing clean energy customer covering ten production-scale coating systems, the largest aggregate order in its history. Shares jumped more than 20% on the news and continued climbing to about $7.16 by October 12.
The reversal began with the fiscal second-quarter 2027 results reported on October 14. Net sales rose just 1% to $5.23 million, while earnings per share of $0.02 missed the $0.05 consensus estimate. Although gross margin expanded to 53% and medical market sales surged 209%, higher operating expenses pressured profitability. Management reiterated full-year guidance of flat-to-modest revenue growth, and the company noted that most of the record order is expected to ship in fiscal 2028, limiting near-term revenue visibility. The combination of the earnings miss, unchanged guidance, and profit-taking after the speculative run-up drove the stock lower through late October and into November.
What Drove SOTK Stock Performance Over the Last Quarter
The broader three-month narrative centers on a business rotating toward medical devices while clean energy softens. First-half fiscal 2027 medical market sales increased 289% to $7.05 million, led by balloon catheter coating and specialty stent-coating systems, as customers moved into commercial production. That strength helped offset a sharp decline in alternative energy demand tied to U.S. policy shifts in green hydrogen and electrolysis.
The record clean-energy order and a $9.51 million backlog (up 23% sequentially) improved visibility into fiscal 2028, and management pulled forward capacity expansion plans to support the ramp. However, near-term earnings pressure, lumpy large-order timing, and the stock's micro-cap liquidity meant the positive long-term signals did not prevent a net decline over the quarter.
Trending AI Robots
Tickeron's Trending AI Robots page highlights a curated selection of top-performing automated trading strategies from a broader universe of hundreds of AI-powered bots that trade thousands of tickers. Only the most relevant and consistently strong performers appear in this section, with bots differing in strategy, holding timeframe, and performance metrics. The page offers a way to observe how data-driven systems approach markets, including stocks with volatile price behavior like Sono-Tek. Investors interested in complementing their own research with algorithm-driven signals can explore Trending AI Robots.
SOTK Stock Forecast Drivers: What Investors Should Watch Next
Looking ahead, investors are likely to focus on the pace of medical device order activity, particularly adoption of balloon catheter and stent-coating production systems, and on the timing of the record clean-energy order's shipments into fiscal 2028. Upcoming quarterly earnings and any updates to the flat-to-modest fiscal 2027 revenue guidance will be key sentiment drivers. Capacity expansion execution, including the phase-one investment planned around December and January, and the ability to convert backlog into recognized revenue will also be closely watched.
Risks include the lumpy timing of large, high-ASP system orders, continued weakness in clean energy segments, rising operating expenses ahead of fiscal 2028 revenue, and the inherent volatility of a micro-cap stock. As of the most recent available coverage, analyst sentiment reflected a Hold rating with a $5.00 price target.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
SOTK in downward trend: 10-day moving average broke below 50-day moving average on October 29, 2026
The 10-day moving average for SOTK crossed bearishly below the 50-day moving average on October 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SOTK as a result. In 78 of 106 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.
The Moving Average Convergence Divergence Histogram (MACD) for SOTK turned negative on October 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 33 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 69%.
SOTK moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SOTK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
The Aroon Indicator for SOTK entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 17 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +5.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where SOTK advanced for three days, in 169 of 228 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
SOTK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.279) is normal, around the industry mean (1.448). P/E Ratio (33.077) is within average values for comparable stocks, (5.350). Projected Growth (PEG Ratio) (0.390) is also within normal values, averaging (5.470). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (3.258) is also within normal values, averaging (32.028).
The Tickeron SMR rating for this company is 68 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 80 (best 1 - 100 worst), indicating slightly worse than average price growth. SOTK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SOTK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry ElectronicEquipmentInstruments